These findings reveal that the FATP1/SLC27A1 gene is undoubtedly relevant on the clinical outcome of BC as more aggressive and invasive carcinomas (TNBC) exhibit a significantly upregulated expression of FATP1/SLC27A1. Here, SLC27A1 is linked to invasive carcinoma.